DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant TherapyFrank A. Sinicrope, Daniel J. Sargent, Nathan R. Foster et al.|JNCI Journal of the National Cancer Institute|2011Cited by 527
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)Scott Kopetz, Howard S. Höchster, Katherine A. Guthrie et al.|Journal of Clinical Oncology|2020Cited by 391
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaperArvind Dasari, Scott Kopetz, Van K. Morris et al.|Nature Reviews Clinical Oncology|2020Cited by 365
Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5‐Fluorouracil TherapyJan H. Beumer, Markus Joerger, Edward Chu et al.|Clinical Pharmacology & Therapeutics|2018Cited by 126
Prognostic importance of thymidylate synthase expression in early breast cancer.Bernhard C. Pestalozzi, Patrick G. Johnston, Harriet F. Peterson et al.|Journal of Clinical Oncology|1997Cited by 124